タイトル無し
スポンサーリンク
概要
- 論文の詳細を見る
In breast cancer mass screening, we compared cases of cancer that had been overlooked by physical examination (PE), ultrasound examination (US) and mammography (MMG), and verified the usefulness of tripartite mass screening using these methods simultaneously. Among 30 cases of cancer detected by tripartite mass screening in a 3-year period, nine cases were overlooked by PE, six by US, and seven by MMG, giving respective detection rates of 70%, 80% and 77%. However, excluding one tumor that was overlooked because it lay outside the MLO field, the detection rate for MMG was 79%. With regard to bipartite mass-screening with two methods, the detection rate for joint PE·US was 90%, that for PE·MMG was 93%, and that for US·MMG was 97%, the latter being the most efficient.<BR>Tumors that had been overlooked by PE and MMG were significantly smaller than those that had been detected, but this was not the case for tumors that had been overlooked by US. Therefore we suggest that oversight during US examination is due to difficulty of diagnostic differentiation between cancer and fatty tissue or cyst, etc. rather than tumor size.<BR>We found that cases overlooked by PE had a significantly lower pathological grade of invasion than cases overlooked by MMG, even though the former tended to show lymphatic metastasis most frequently. Furthermore, all of these metastatic breast cancers had a smaller diameter ranging from 0.8cm to 0.9cm.<BR>Our results suggest that joint use of US·MMG mass screening without PE is the most efficient approach. However, because the current mass screening program also involves PE, we conclude that tripartite mass screening is still the best method.
- 日本乳癌検診学会の論文
日本乳癌検診学会 | 論文
- Characteristics of Patients with Interval Breast Carcinomas.
- Evaluation of Mass Screening for Breast Cancer Conducted under the Health and Medical Service Law for the Elderly and the Actual Conditions of Health Insurance Administration in Zentsuji City.
- Two Cases of Mucinous Carcinoma of the Breast Manifested as Interval Cancer.
- Breast-Conserving Therapy for Breast Cancer Patients Showing Mammographic Evidence of Calcification.
- タイトル無し